What is a Cognoscopy?
Many know about colonoscopy and gastroscopy studies and will readily engage in these to manage there physical health. However, no one considers Brain Health and the fact that the same investigations can occur with the brain.
A “Cognoscopy,” a term introduced by neurologist Dr. Dale Bredesen, is a comprehensive assessment aimed at evaluating and preserving cognitive health.
This evaluation encompasses a series of tests, including laboratory analyses, cognitive assessments, and medical history evaluations, and brain imaging, to identify risk factors associated with cognitive decline, such as Alzheimer’s disease.
The assessment typically involves:
- Blood Tests: These tests detect metabolic imbalances, inflammation, hormonal discrepancies, toxicity levels, nutritional deficiencies, and genetics that may contribute to cognitive decline.
- Cognitive Function Testing: Simple, online cognitive assessments help determine current cognitive performance and identify any areas of concerns.
- Medical History Evaluation: A thorough review of the patient’s medical history to uncover potential risk factors.
- QEEG Scan: QEEG or quantitative Electroencephalogram has the ability to identify functional brain changes associated with cognitive decline. Neuroperformance, uses the iMedisync system, with a world first evidence based process that allows the screening of your EEG to predict the stage of decline you may be with well before any MRI can. This has Korean FDA approval. TGA have yet to evaluate this new tool. However, ensuring you are fully informed, we will use this powerful analysis as we focus on prevention.
While commonly associated with aging and concerns about dementia, a Cognoscopy is beneficial for individuals of all ages. It’s particularly relevant for those who have experienced concussions or “Covid Brain,” as both conditions can impact cognitive function. Early detection through a Cognoscopy allows for timely interventions to address these issues effectively.
Dr. Bredesen recommends that adults aged 45 or older undergo a Cognoscopy to identify Alzheimer’s disease risks early, facilitating more effective prevention and treatment strategies.
Regardless of age or current cognitive health, undergoing a Cognoscopy can help identify potential risks and offer tailored recommendations to support optimal brain function.
At Neuroperformance, we will use the data obtained to build a program to improve your brain’s health. There is sufficient evidence to support the prevention of certain types of dementia and even to support the ability stop progression or even improve the early stages of mild cognitive impairment. Some of this evidence if very new, emerging and in need of replication. Keeping you fully informed, we will offer the best the current evidence has on offer (even if regarded as still experimental we will discuss this and explore if this is right for you as long as we know it will do no harm).